OXT and epilepsy: Altogether, our findings may provide insight into the clinical translation of neuropeptide oxytocin that is promisingly implicated in treating epilepsy and cognitive decline occurring after traumatic brain injury via BBB enhancement in the medial prefrontal cortex.